RudaCure project number: VC230007
The project is scheduled to run for two years starting November 1, 2023, with the goal of developing an osteoarthritis pain treatment.
IP Darae Strategic Commercialization Center is designated as the operating agency for this project and will be collaborating with RudaCure on the initiative.